About the Journal
Journal of Hematology and Transfusion Medicine
ISSN 2985-2390 (Print)
ISSN 2985-2404 (Online) (Since October 2023)
Aims and Scope
Journal of Hematology and Transfusion Medicine is a quarterly peer-reviewed journal that encourages ongoing international research and exchange of scientific literature among peers through publication of research, review, case report, short communication and editorial. The articles related to the most recent advancement in the field would be very supportive for the researchers, scholars and academicians in hematology and transfusion medicine. All the articles published online are made publicly available in the PDF files for free-of-charge.
Journal of Hematology and Transfusion Medicine is an official Journal of the Thai Society of Hematology and the National Blood Centre, Thai Red Cross Society. However, contributions written in English are welcomed from around the world, submit your manuscript using our online submission system or on the website at https://www.tci-thaijo.org/index.php/JHematolTransfusMed. If you require any further information or help, please contact the editorial office at sommaphun.t@tsh.or.th or nbcjournal@gmail.com.
Type of paper: Original article, Case report, Review article, Special article
Language: Fulltext in English, abstract both in Thai and English
Free Access: Online
Publication Frequency
Quarterly, 4 issues a year
- Issue 1 January-March
- Issue 2 April-June
- Issue 3 July-September
- Issue 4 October-December
Abstracting and indexing
- Thailand Citation Index Center (TCI), our journal is indexed in the Tier 1 database of the TCI.
- Google Scholar
Peer Review Process
JHTM has double-blind peer-review process. The editorial board consists of professor, associate professor and assistant professor in fields of Hematology and Transfusion Medicine, who have experience in conducting and publishing research. At least three reviewers evaluate manuscript. Initial reviews usually accomplish within 4 weeks.
Article Processing Charges
There are no fees for all types of artcles for publication.
Subscription
For hard copy subscription, the annual subscription rate is 8 USD / year or life membership fee 80 USD
Research and publication ethics
All human and animal research studies must be reviewed and approved by the author’s Institutional Review Board (IRB). The clinical trials must be registered in a public registry prior to enrollment, the journal accepts public registry that follow the International Committee of Medical Journal Editors (ICMJE) clinical trial registration policy (https://www.icmje.org).The clinical research involving human subjects must comply with the Declaration of Helsinki https://www.wma.net/en/20activities/10ethics/10helsinki/.
The author should be checked your manuscript before submit to the journal, to confirm that none of the parts of the manuscript is plagiarized from any other sources. The corresponding author must complete the journal form for Disclosure of Potential Conflicts of Interest and submit the form on behalf of all co-authors.
Roles and Responsibilities of Authors
The author should be checked the manuscript before submit to the journal, to confirm that
- The manuscript is an original work and has not been previously published or submitted elsewhere for consideration.
- The research data and results are not manipulated or fabricated.
- Data, images, words or ideas taken from the works of others should be properly acknowledged and the sourced of content must always be cited. A list of references must be written according to the journal’s format and be placed at the end of the manuscript.
- The manuscript was prepared correctly according to “Author Guidelines”.
- Each author whose name appears on the manuscript were significantly participate in conducting the research or writing the manuscript.
- All sources of research funding and conflict of interest were disclosed.
Roles and Responsibilities of Editors
- The editors are responsible for determining the quality of all manuscripts that are published in the journal. After the editorial review process, the editors should make the decision to select the manuscripts for publication based on significance, relevance, clarity and consistency of the content with the editorial policies
- The editors must keep all information of the authors and reviewers confidential during the review process of a manuscript.
- The editors must not accept any manuscripts that have been previously published and have conflicts of interest with authors, reviewers, and editorial management team.
- The editors should use a reliable program to check plagiarism of the manuscripts.
If plagiarism is detected, the editors will terminate the review process and immediately contact the corresponding author for clarification before making the decision to “accept” or “reject” the manuscript.
Roles and Responsibilities of Reviewers
- After receiving a manuscript from the editors, if the reviewers realize that they may have conflicts of interest with the authors, resulting from collaboration, relationship, connection, or other reasons that may lead to bias or inability to provide independent opinions and suggestions, they should notify the editors and refuse to review the manuscript immediately.
- During the editorial review process, the reviewers must keep all information of the manuscript confidential.
- The reviewers should review a manuscript based on its significance of the content in the relation to the field of study, the quality of analysis, and the intensity of results. Unsupported personal opinions should not be used as a basis for judging the manuscript.
- The reviewers should identify plagiarisms, if the authors do not provide citations. Also, if any part of the manuscript is identical with or duplicated from other articles, the reviewers must notify the editors immediately.
Manuscript preparation
Manuscripts should be submitted in the format of Microsoft Word, the body text should be typed in Angsana UPC, using font size 16 with 1.5 line spacing and number all pages in sequence.
Type of articles
Original article: All submitted manuscripts being considered for publication undergo peer-review by at least three reviewers who are experts in the field of your research. The original articles should be no more than 5,000 words in length and should contain the following sections:
- Title page that includes the full title, short running title of 75 characters with space, name(s) and affiliation(s) of all author(s), email address, telephone and fax numbers of the corresponding author.
- Abstract is a concise summary of your research that includes the objective, materials and methods, results, conclusion and at least 2 and up to 5 keywords. The length is limited to 250 words.
- Introduction and Objective
- Materials and Methods
- Results
- Discussion
- Conclusion
- Acknowledgment
- References
- Tables
- Figures and Figure legends
Review article : Review article is generally solicited by the Editor-in-Chief, however, authors who wish to submit a review article are invited to contact the editorial office prior to submission. The review articles should be no longer than 5,000 words and should include the following sections:
- Introduction
- Text
- Conclusion
- References
Case report: Submissions will be considered for publication by the editor. Case reports should contain the briefly review the relevant literature, the text is limited to 5,000 words and must include the following sections;
- Abstract should be concise, contain no more than 250 words and 2- 5 keywords are required.
- Introduction
- Text
- Conclusion
- References
Short communication: Short communication is a brief summary of recently updated articles from high quality journals in Hematology. It is usually written by editorial team.
Editorial: Editorial is generally written by Editorial Board members that focuses on the issues related to the publishing articles.
References
- Standard journal article (less than six authors)
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
- Standard journal article (more than six authors)
Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935:40-6.
- Article published electronically ahead of the print version
Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood. 2002 Nov 15;100(10):3828-31. Epub 2002 Jul 5.
- Book chapter
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
- Volume with supplement
Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:S93-9.
- Issue with supplement
Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002;58(12 Suppl 7):S6-12.
- Journal article on the Internet
Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 1 p.]. Available from: https://www.nursingworld.org/AJN/2002/june/Wawatch.htmArticle.
- Article with a Digital Object Identifier (DOI):
Zhang M, Holman CD, Price SD, Sanfilippo FM, Preen DB, Bulsara MK. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ. 2009;338:a2752. doi: 10.1136/bmj.a2752. PubMed PMID: 19129307; PubMed Central PMCID: PMC2615549.
- Conference proceedings
Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.
- Conference paper
Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.
Table: Table must be presented at the end of manuscript on separate pages and numbered consecutively with Arabic numerals.
Figure: Electronically submitted figures should be in one of the following formats: portable data format (.pdf), tiff, bitmap (.bmp), jpeg (.jpg).
Image File: Image file of Hematology should be submitted in JPEG format. Images should have a minimum resolution of 600 dpi or higher.
Conflicts of Interest Form
Upload Disclosure of Potential Conflicts of Interest Form.
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Sponsor and source of support
National Blood Centre, Thai Red Cross Society and the Thai Society of Hematology
